Source: BSAA Remote Desktop
Project Umbrella Translation
NEWS CONCERNING UMBRELLA'S BANKRUPTCY
PHARMA-COMPANY UMBRELLA'S DOMESTIC BUSINESS TO DISSOLVE
In response to the bankruptcy of the global pharmaceutical company "Umbrella", its Japanese subsidiary "Umbrella Japan Co., Ltd" (headquarters: Tokyo) has announced the company's dissolution and entered liquidation proceedings.
The domestic company was established in 1984 as Umbrella's Japanese subsidiary. At the time of its establishment, it was merely engaged in importing and distributing drugs developed in the USA, but in 1987, the "Umbrella Japan Laboratory" was constructed. It advanced unique research and product development utilizing our nation's forte in biotechnology.
Following the "Raccoon City tragedy" allegedly caused by Umbrella, however, its stock prices crashed.
Sales have also faltered in recent years, partly due to reputational damage.
After a multitude of lawsuits concerning the Raccoon City tragedy resulted in Umbrella Headquarters losing all its cases, the head office went bankrupt.
As a Japanese subsidiary the domestic company sought a takeover buyer, but since no interest was exhibited by any domestic or foreign pharma-companies or even enterprises in other industries, the company's dissolution was decided upon.
March 15, 2004
Excerpt from a certain newspaper's morning edition
PHARMA-COMPANY UMBRELLA'S DOMESTIC BUSINESS TO DISSOLVE
In response to the bankruptcy of the global pharmaceutical company "Umbrella", its Japanese subsidiary "Umbrella Japan Co., Ltd" (headquarters: Tokyo) has announced the company's dissolution and entered liquidation proceedings.
The domestic company was established in 1984 as Umbrella's Japanese subsidiary. At the time of its establishment, it was merely engaged in importing and distributing drugs developed in the USA, but in 1987, the "Umbrella Japan Laboratory" was constructed. It advanced unique research and product development utilizing our nation's forte in biotechnology.
Following the "Raccoon City tragedy" allegedly caused by Umbrella, however, its stock prices crashed.
Sales have also faltered in recent years, partly due to reputational damage.
After a multitude of lawsuits concerning the Raccoon City tragedy resulted in Umbrella Headquarters losing all its cases, the head office went bankrupt.
As a Japanese subsidiary the domestic company sought a takeover buyer, but since no interest was exhibited by any domestic or foreign pharma-companies or even enterprises in other industries, the company's dissolution was decided upon.
March 15, 2004
Excerpt from a certain newspaper's morning edition
Official Japanese Transcript
UMBRELLA倒産に関するNEWS
製薬企業アンブレラの国内法人、会社解散へ
世界的製薬企業である「アンブレラ」の倒産を受け、日本法人である「アンブレラ・ジャパン（株）」（本社：東京）は、会社の解散を発表、清算手続きに入った。
当社は１９８４年にアンブレラの日本法人として設立。設立当時は米国で開発された薬品の輸入販売のみを行っていたが、１９８７年に"アンブレラ日本研究所"を建設。当社の強みであるバイオテクノロジーを活かし、独自の研究、製品の開発を進めていた。
しかし、アンブレラが原因とされる「ラクーンシティの惨劇」を皮切りに株価が暴落。
近年は風評被害も手伝い、売り上げが低迷していた。
ラクーンシティの惨劇に関する数々の訴訟がアンブレラ本社の全面敗訴に終ったため、本社が倒産。
日本法人である当社は、引き取り先を探していたが、国内外の製薬会社だけではなく、他業種の企業も興味を示さなかったため、会社解散に踏み切った。
2004年3月15日 某新聞朝刊より抜粋
製薬企業アンブレラの国内法人、会社解散へ
世界的製薬企業である「アンブレラ」の倒産を受け、日本法人である「アンブレラ・ジャパン（株）」（本社：東京）は、会社の解散を発表、清算手続きに入った。
当社は１９８４年にアンブレラの日本法人として設立。設立当時は米国で開発された薬品の輸入販売のみを行っていたが、１９８７年に"アンブレラ日本研究所"を建設。当社の強みであるバイオテクノロジーを活かし、独自の研究、製品の開発を進めていた。
しかし、アンブレラが原因とされる「ラクーンシティの惨劇」を皮切りに株価が暴落。
近年は風評被害も手伝い、売り上げが低迷していた。
ラクーンシティの惨劇に関する数々の訴訟がアンブレラ本社の全面敗訴に終ったため、本社が倒産。
日本法人である当社は、引き取り先を探していたが、国内外の製薬会社だけではなく、他業種の企業も興味を示さなかったため、会社解散に踏み切った。
2004年3月15日 某新聞朝刊より抜粋
Official English Transcript
NEWSPAPER ARTICLE ABOUT THE FALL OF UMBRELLA
Domestic Branch of Umbrella to Dissolve
TOKYO, JAPAN: Today, the Japanese branch of multinational corporation Umbrella Pharmaceutical Incorporated announced its dissiolution and began liquidating assets. Its parent company declared bankruptcy earlier this week.
Umbrella established its Japanese branch in 1984 for the initial purpose of importing pharmaceuticals developed in America. In 1987, it completed the Umbrella Japan Research Center, which used biotechnology to pursue independent research and pharmaceutical development.
Umbrella's stocks had been on the decline following accusations regarding the 1998 "Raccoon City Tragedy," and the blow to public image has caused its sales to stagnate. With Umbrella recently found liable in numerous lawsuits filed against them in the wake of that same tragedy, the company was forced to declare bankruptcy.
The Japanese branch of the company has been looking for new sources of funding in recent weeks, but received no offers from pharmaceutical or other companies at home or abroad. The decision to close was made in light of this fact.
(Excerpt from a certain newspaper's morning edition, 3/15/2004
Domestic Branch of Umbrella to Dissolve
TOKYO, JAPAN: Today, the Japanese branch of multinational corporation Umbrella Pharmaceutical Incorporated announced its dissiolution and began liquidating assets. Its parent company declared bankruptcy earlier this week.
Umbrella established its Japanese branch in 1984 for the initial purpose of importing pharmaceuticals developed in America. In 1987, it completed the Umbrella Japan Research Center, which used biotechnology to pursue independent research and pharmaceutical development.
Umbrella's stocks had been on the decline following accusations regarding the 1998 "Raccoon City Tragedy," and the blow to public image has caused its sales to stagnate. With Umbrella recently found liable in numerous lawsuits filed against them in the wake of that same tragedy, the company was forced to declare bankruptcy.
The Japanese branch of the company has been looking for new sources of funding in recent weeks, but received no offers from pharmaceutical or other companies at home or abroad. The decision to close was made in light of this fact.
(Excerpt from a certain newspaper's morning edition, 3/15/2004